| |
Latest 10 SEC filings (by transaction date) for CABA within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 4/24 | Mar 1/24 | Gerard Michael | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 100,000 | |
Mar 4/24 | Mar 1/24 | Chang David J. | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 130,000 | |
Mar 4/24 | Mar 1/24 | Nichtberger Steven | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 353,000 | |
Mar 4/24 | Mar 1/24 | Marda Anup | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 130,000 | |
Mar 4/24 | Mar 1/24 | Das Arun | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 100,000 | |
Mar 4/24 | Mar 1/24 | Binder Gwendolyn | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 130,000 | |
Jan 19/24 | Jan 19/24 | Binder Gwendolyn | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -11,000 | |
Jan 19/24 | Jan 19/24 | Binder Gwendolyn | Direct Ownership | Common Stock | S - Open market or private sale | -700 | $20.33 |
Jan 19/24 | Jan 19/24 | Binder Gwendolyn | Direct Ownership | Common Stock | S - Open market or private sale | -10,300 | $19.54 |
Jan 19/24 | Jan 19/24 | Binder Gwendolyn | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 11,000 | $1.01 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for CABA within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 4/24 | Mar 1/24 | Gerard Michael | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 100,000 | |
Mar 4/24 | Mar 1/24 | Chang David J. | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 130,000 | |
Mar 4/24 | Mar 1/24 | Nichtberger Steven | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 353,000 | |
Mar 4/24 | Mar 1/24 | Marda Anup | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 130,000 | |
Mar 4/24 | Mar 1/24 | Das Arun | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 100,000 | |
Mar 4/24 | Mar 1/24 | Binder Gwendolyn | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 130,000 | |
Jan 19/24 | Jan 19/24 | Binder Gwendolyn | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -11,000 | |
Jan 19/24 | Jan 19/24 | Binder Gwendolyn | Direct Ownership | Common Stock | S - Open market or private sale | -700 | $20.33 |
Jan 19/24 | Jan 19/24 | Binder Gwendolyn | Direct Ownership | Common Stock | S - Open market or private sale | -10,300 | $19.54 |
Jan 19/24 | Jan 19/24 | Binder Gwendolyn | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 11,000 | $1.01 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |